Efficacy and Safety of Mavacamten and Aficamten in Obstructive and Non-obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis

By afschroeder • February 5, 2026

Ibrahim M, Kashif A, Arfin SMW, Mubeen M, Zafar A, Balach R, Musani MH, Greene SJ, Fonarow GC, Sohail MU. Efficacy and Safety of Mavacamten and Aficamten in Obstructive and Non-obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis. Crit Pathw Cardiol. 2026 Jan 30. doi: 10.1097/HPC.0000000000000418. Epub ahead of print. PMID: 41641607.

Tags: aficamten, cardiac myosin inhibitors, Cardiology/Epi, Hypertrophic cardiomyopathy, Left ventricular outflow tract gradient, Mavacamten, meta-analysis, Publications, Randomized Controlled Trials

ENPP1 blockade with a humanized monoclonal antibody enhances renal repair after acute kidney injury

Su L, Sun Q, Zhou Z, Wang R, Wang J, Alvarez JF, Tao B, Das K, Zhou Q, Wang J, Zhang G, Ten Hoeve J,[...]

Electrophysiological Effects of Right and Left Tragus Nerve Stimulation in Humans

Olarte N, Nguyen H, Krokhaleva Y, Khakpour H, Do D, Hayase J, Macias C, Stavrakis S, Vaseghi M. Electrophysiological Effects of Right and Left Tragus[...]

Sisyphean Task of Cardiovascular Prevention: Real Gains, Unequal Progress

Ziaeian B, Fonarow GC. Sisyphean Task of Cardiovascular Prevention: Real Gains, Unequal Progress. Circulation. 2026 Jun 16;153(24):1879-1881. doi: 10.1161/CIRCULATIONAHA.126.080394. Epub 2026 Jun 15. PMID: 42296212;[...]